InvestorsHub Logo
Followers 37
Posts 2256
Boards Moderated 0
Alias Born 05/10/2016

Re: None

Wednesday, 11/17/2021 12:38:39 PM

Wednesday, November 17, 2021 12:38:39 PM

Post# of 198752
$enzc Some generic raw numbers
2% US (50B) markeshare for @enzoimmune immunomodulator
$1B revenue
Stock valuation of 10x 15x 20x = share price $3.57 $5.35 $7.14
2% of global market (200B) do a 4x those values
This doesn't include anything with mABs, just the immunomodulator